These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 11523596)
1. Inhibition of protein oxidation by the macrophage-synthesised antioxidant 7,8-dihydroneopterin. Duggan S; Rait C; Gebicki JM; Gieseg SP Redox Rep; 2001; 6(3):188-90. PubMed ID: 11523596 [No Abstract] [Full Text] [Related]
2. Protein and thiol oxidation in cells exposed to peroxyl radicals is inhibited by the macrophage synthesised pterin 7,8-dihydroneopterin. Duggan S; Rait C; Platt A; Gieseg S Biochim Biophys Acta; 2002 Aug; 1591(1-3):139-145. PubMed ID: 12183064 [TBL] [Abstract][Full Text] [Related]
3. 7,8 Dihydroneopterin inhibits low density lipoprotein oxidation in vitro. Evidence that this macrophage secreted pteridine is an anti-oxidant. Gieseg SP; Reibnegger G; Wachter H; Esterbauer H Free Radic Res; 1995 Aug; 23(2):123-36. PubMed ID: 7581810 [TBL] [Abstract][Full Text] [Related]
4. Spin trapping study of antioxidant properties of neopterin and 7,8-dihydroneopterin. Oettl K; Dikalov S; Freisleben HJ; Mlekusch W; Reibnegger G Biochem Biophys Res Commun; 1997 May; 234(3):774-8. PubMed ID: 9175792 [TBL] [Abstract][Full Text] [Related]
5. Protection of erythrocytes by the macrophage synthesized antioxidant 7,8 dihydroneopterin. Gieseg SP; Maghzal G; Glubb D Free Radic Res; 2001 Feb; 34(2):123-36. PubMed ID: 11264890 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of haemolysis by the macrophage synthesized antioxidant, 7,8-dihydroneopterin. Gieseg SP; Maghzal G; Glubb D Redox Rep; 2000; 5(2-3):98-100. PubMed ID: 10939282 [No Abstract] [Full Text] [Related]
7. Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis. Gieseg SP; Crone EM; Flavall EA; Amit Z Br J Pharmacol; 2008 Feb; 153(4):627-35. PubMed ID: 17700723 [TBL] [Abstract][Full Text] [Related]
8. Protection of U937 cells from free radical damage by the macrophage synthesized antioxidant 7,8-dihydroneopterin. Gieseg SP; Whybrow J; Glubb D; Rait C Free Radic Res; 2001 Sep; 35(3):311-8. PubMed ID: 11697129 [TBL] [Abstract][Full Text] [Related]
9. Macrophage mediated protein hydroperoxide formation and lipid oxidation in low density lipoprotein are inhibited by the inflammation marker 7,8-dihydroneopterin. Firth CA; Crone EM; Flavall EA; Roake JA; Gieseg SP Biochim Biophys Acta; 2008 Jun; 1783(6):1095-101. PubMed ID: 18342632 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of monocyte luminol-dependent chemiluminescence by tetrahydrobiopterin, and the free radical oxidation of tetrahydrobiopterin, dihydrobiopterin and dihydroneopterin. Heales SJ; Blair JA; Meinschad C; Ziegler I Cell Biochem Funct; 1988 Jul; 6(3):191-5. PubMed ID: 3409479 [TBL] [Abstract][Full Text] [Related]
11. Quantification of total oxidant scavenging capacity of antioxidants for peroxynitrite, peroxyl radicals, and hydroxyl radicals. Regoli F; Winston GW Toxicol Appl Pharmacol; 1999 Apr; 156(2):96-105. PubMed ID: 10198274 [TBL] [Abstract][Full Text] [Related]
12. Antioxidant properties of ticlopidine on human low density lipoprotein oxidation. Lapenna D; de Gioia S; Ciofani G; Bruno C; Porreca E; Pierdomenico SD; Cuccurullo F FEBS Lett; 1998 Oct; 436(3):357-60. PubMed ID: 9801148 [TBL] [Abstract][Full Text] [Related]
13. Oxidant production, oxLDL uptake, and CD36 levels in human monocyte–derived macrophages are downregulated by the macrophage-generated antioxidant 7,8-dihydroneopterin. Gieseg SP; Amit Z; Yang YT; Shchepetkina A; Katouah H Antioxid Redox Signal; 2010 Nov; 13(10):1525-34. PubMed ID: 20408759 [TBL] [Abstract][Full Text] [Related]